Description

Molecular Mechanism of Action

BIOT100 stands as a paramount achievement in the field of molecular aesthetic bio-engineering. This high-potency solution is specifically formulated for the management of dynamic facial rhythms, offering a definitive botox-like response through a non-invasive protocol. The core of its efficacy lies in the strategic modulation of the neurotransmitter pathways responsible for muscle fiber contraction.

The active complex within BIOT100 utilizes a high concentration of biomimetic hexapeptides, which are strictly engineered to interfere with the SNARE protein assembly. By destabilizing this complex, the solution inhibits the exocytosis of acetylcholine at the neuromuscular junction. This process results in a controlled relaxation of the facial micro-tensions that lead to the formation and deepening of the glabellar lines, forehead furrows, and periorbital “crow’s feet.”

Advanced Transdermal Delivery System

A critical component of its clinical profile is the pharmaceutical-grade transdermal vehicle. This carrier ensures that the peptide molecules maintain their structural integrity as they permeate the stratum corneum and move toward the deeper dermal-epidermal junction. This method of transdermal administration allows for a high bioavailability of the active principles, ensuring they reach the targeted synaptic receptors with maximum efficacy without invasive measures.

Structural Dermal Redensification

Beyond its immediate myo-relaxant action, BIOT100 encourages the long-term redensification of the extracellular matrix (ECM). By fostering a stable environment for fibroblast activity, it stimulates the synthesis of endogenous type I collagen and elastin. This dual-action approach renders BIOT100 the premier choice for professional protocols aiming to postpone or complement clinical procedures.